FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.3 million.
Excluding non-cash expenses, Adjusted EBITDA for the three months ended March 31, 2015 would have... More

